Jim Breyer

Solo Angel AI focus Menlo Park, CA, United States

About Jim Breyer

Jim Breyer is the founder of Breyer Capital, an early Facebook investor, and one of the most senior solo capital allocators in the venture industry, based in Menlo Park with $250k+ checks at seed and Series A in AI/ML in healthcare and health IT software. A personal check from Breyer is a category-defining signal that pulls institutional capital and opens doors across the healthcare and AI ecosystem. Founders building AI-native healthcare software with category-defining ambition, platforms targeting multi-billion-dollar outcomes, or companies where his AI-thesis credibility (he has been vocal on AI investment for years) and global network add meaningful value are the only realistic fit. He is the wrong audience for narrow point solutions, small-market plays, biotech without an AI angle, or anything that doesn’t credibly target IPO-scale outcomes. Cold outreach is essentially non-viable; founders should invest in warm introductions through Breyer Capital portfolio CEOs, the Stanford and Harvard networks where he is active, or top-tier institutional VCs that frequently co-invest. Twitter (@jimihbreyer) is a relationship-building surface but not a pitch channel. Diligence expectations will be commensurate with the check size and signal value: come with a clear AI thesis, defensible technical strategy, and a credible team. Founders without obvious access should redirect energy toward reachable investors and revisit later.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.
Portfolio data coming soon. Know their portfolio? Suggest an edit →
Team information coming soon. Know the partners? Suggest an edit →

Pitch / review this investor

Have you raised from Jim Breyer? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.